# Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease

Study · id `cardio:ct-nct03864081` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03864081](<https://clinicaltrials.gov/study/NCT03864081>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03864081

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2500 participants.

## Technical summary

Registry record NCT03864081. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-12-10 (actual); primary completion 2022-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 2500 participants (planned count; ClinicalTrials.gov record NCT03864081, source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)
- Started: 2018-12-10 (actual) (ClinicalTrials.gov record NCT03864081, source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)
- Primary completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT03864081, source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)
- Completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT03864081, source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03864081, source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03864081-2022-01-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease
- Acronym: IDENTIFY
- Condition: Coronary Artery Disease
- Intervention (Device): Phase Signal Recorder
- Lead sponsor: Analytics For Life
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Analytics For Life (`cardio:org-analytics-for-life`)

## Provenance

Content hash: fc4aa9569d03aa7ca4f5b3a5c8caf696429d0cca5214e72d951eefbdaa89d142
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
